We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo






  Request new password

Search results

Order by most recent / most popular / relevance

Results: 11-20 of 38

Colorado life sciences industry benefits from increased VC investments in 2011

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • March 1 2012

A Boulder, Colorado-based company that tracks, analyzes and reports global bioscience venture capital investment activity has released a report on 2011 trends, finding an increase in funding and deals from 2010

New program to provide accelerated “speed-to-market” for medical device entrepreneurs

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • March 1 2012

The nonprofit Memphis Bioworks Foundation and Innova, a pre-seed, seed and early-stage investor, have announced a program designed to help entrepreneurs bring medical device products and companies to market

Viropharma to acquire Swedish pharma in deal worth up to $164.6 million

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • November 3 2011

Pennsylvania-based ViroPharma Inc. has reportedly signed a deal to acquire Swedish company DuoCort Pharma AB to expand its orphan disease commercial product pipeline

Indian officials to scrutinize pharmaceutical M&As

  • Shook Hardy & Bacon LLP
  • -
  • India
  • -
  • October 20 2011

Indian ministry officials have apparently decided that foreign companies may continue to invest in new pharmaceutical industry projects but that foreign proposals for mergers and acquisitions in this sector will have to undergo enhanced scrutiny

Company secures $10 million in venture capital financing to improve DNA sequencing technology

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • September 22 2011

NABsys, Inc., a Rhode Island-based developer of electronic systems used for sequencing and analyzing single-molecule DNA, has reportedly raised $10 million in new venture capital funding, closing a Series C preferred stock financing round

Cincinnati investor closes $4.4 million fund to invest in startups

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • June 30 2011

Cincinnati-based CincyTech, a venture development company that invests in startup biotech, information technology and advanced manufacturing businesses, has announced the closing of a $4.4 million Fund II targeted for 10 to 12 new startups in southwest Ohio

Financial group analyzes M&A deals in biotech and medical device industries

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • June 16 2011

According to an SVP Financial Group report, contrary to conventional wisdom, biotech exits occur faster than device exits and have lower, but solid, multiples on invested capital

North Carolina life sciences companies attract more than $1.1 billion in investments, grants

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • May 19 2011

After conducting its yearly survey of media reports, a North Carolina trade association has announced that life sciences companies brought in more than $1.1 billion in investments and grants to the state in the 12 months ending April 25, 2011, representing a 25 percent increase over the 12-month period ending April 2010

Moneytree report shows increased life sciences investments in Q1 2011

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • May 19 2011

According to a PricewaterhouseCoopers report on venture capital investments, although fewer deals occurred in the first quarter of 2011 (Q1 2011) as compared to the last quarter of 2010, investment activity increased 5 percent overall

Mergers affect Boston biotech independence

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • April 21 2011

Biotech company executives meeting recently in Boston, were reportedly concerned about the growing buy-out trend among area businesses

Current Search

Suggested Facets

Author

Jurisdiction

Workarea

© Copyright 2006-2013 Globe Business Publishing Ltd | Cookies | Disclaimer | Privacy policy